Skip to main content Back to Top
Advertisement

Overview of Vaping in Pediatrics

Broadcast Date: May 19, 2022

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast episode provides an overview of vaping with an additional emphasis on use in the adolescent population. Topics will include an overview of vaping devices, changes in adolescent use over the past several years, and management of associated lung injury.

SPEAKERS

Livia LindenLivia Linden, PharmD, is a postgraduate year 2 pediatric pharmacy resident at Monroe Carell Jr. Children’s Hospital at Vanderbilt in Nashville, Tennessee. Dr. Linden graduated with her Doctor of Pharmacy degree from Belmont University College of Pharmacy in 2020. She went on to complete a PGY1 pediatric pharmacy residency at Monroe Carell Jr. Children’s Hospital at Vanderbilt and stayed to complete her PGY2 pediatric residency. Her practice interests include pediatrics, critical care, and cardiology.

Jordan BurdineJordan Burdine, PharmD, MBA, BCPPS, is a clinical pharmacy practice specialist in Pediatrics and Neonatology at UTMB Health in Galveston, Texas. Dr. Burdine graduated with her Doctor of Pharmacy degree from Texas Tech University Health Sciences Center School of Pharmacy (TTUHSC-SOP) in 2015. She went on to complete a PGY1 pharmacy residency at West Virginia University Medicine, followed by a PGY2 pediatrics residency at TTUHSC-SOP. At UTMB, Dr. Burdine works as part of the neonatal interdisciplinary team, precepts pharmacy students and residents, provides education to physicians and nurses, and assists in the development of guidelines and protocols for the UTMB Department of Pediatrics. 

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.